Clin Mol Hepatol.
2017 Jun;23(2):123-124. 10.3350/cmh.2017.0107.
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- KMID: 2413114
- DOI: http://doi.org/10.3350/cmh.2017.0107
Abstract
- No abstract available.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatments Other than Sorafenib for Patients with Advanced Hepatocellular Carcinoma
- Two cases of advanced hepatocellular carcinoma achieving a complete response with metronomic chemotherapy via the hepatic artery
- Complete Response of Single Nodular Large Hepatocellular Carcinoma with Pulmonary Metastasis by Sequential Transarterial Chemoembolization and Sorafenib: A Case Report
- The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma
- Treatment options after sorafenib failure in patients with hepatocellular carcinoma
